Genetic Signatures’ CEO, John Melki, talks with Nadine Blayney from AusBiz

ausbiz-john-melki-webinar-thumbnail

Genetic Signatures’ CEO Dr John Melki was recently interviewed by Nadine Blayney from AusBiz about the Company’s unique 3base® technology, its advantages for detecting infectious diseases, the development pipeline, revenue sources, and plans for further investment and expansion in key international markets.

Read More